{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:09:14Z","timestamp":1781179754782,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060483"],"award-info":[{"award-number":["82060483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2024GXNSFAA010396"],"award-info":[{"award-number":["2024GXNSFAA010396"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tranon.2025.102646","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:08:17Z","timestamp":1767683297000},"page":"102646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway"],"prefix":"10.1016","volume":"64","author":[{"given":"Jinhui","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-4868","authenticated-orcid":false,"given":"Mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-0567","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tranon.2025.102646_bib0001","first-page":"171","article-title":"Breast cancer treatment","volume":"104","author":"Trayes","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"5","key":"10.1016\/j.tranon.2025.102646_bib0002","first-page":"519M","article-title":"Metastatic breast cancer","volume":"88","author":"Peart","year":"2017","journal-title":"Radiol. Technol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0003","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0004","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/138920310791824057","article-title":"The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention","volume":"11","author":"Chen","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"issue":"4","key":"10.1016\/j.tranon.2025.102646_bib0006","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/ijms19041080","article-title":"Ubiquitin System","volume":"19","author":"Nakamura","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7138","key":"10.1016\/j.tranon.2025.102646_bib0007","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nature05694","article-title":"Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities","volume":"446","author":"Stegmeier","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0008","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1073\/pnas.94.6.2362","article-title":"Dominant-negative cyclin-selective ubiquitin carrier protein E2-C\/UbcH10 blocks cells in metaphase","volume":"94","author":"Townsley","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tranon.2025.102646_bib0009","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2013.11.023","article-title":"Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker","volume":"47","author":"Xie","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"14","key":"10.1016\/j.tranon.2025.102646_bib0010","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1158\/0008-5472.CAN-10-4576","article-title":"CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.tranon.2025.102646_bib0011","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15384101.2017.1356507","article-title":"Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death","volume":"16","author":"Guo","year":"2017","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.tranon.2025.102646_bib0012","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00432-012-1275-2","article-title":"UbcH10 expression provides a useful tool for the prognosis and treatment of non-small cell lung cancer","volume":"138","author":"Zhao","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0013","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-022-06531-5","article-title":"Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer","volume":"192","author":"Kariri","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41420-022-00935-4","article-title":"Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma","volume":"8","author":"Xiang","year":"2022","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/1541-7786.MCR-22-0825","article-title":"UBE2C-mediated autophagy inhibition via ubiquitination of SIRT1 contributes to endometrial cancer progression","volume":"21","author":"Zhao","year":"2023","journal-title":"MCR"},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0016","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/15384047.2017.1416939","article-title":"UBE2C promotes rectal carcinoma via miR-381","volume":"19","author":"Zhang","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-022-06531-5","article-title":"Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer","volume":"192","author":"Kariri","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.tranon.2025.102646_bib0018","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3389\/fonc.2019.01574","article-title":"UBE2C Overexpression aggravates patient outcome by promoting estrogen-dependent\/independent cell proliferation in early hormone receptor-positive and HER2-negative breast cancer","volume":"9","author":"Kim","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102646_bib0019","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2019.08.010","article-title":"Mechanisms of interplay between transcription factors and the 3D genome","volume":"76","author":"Kim","year":"2019","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.tranon.2025.102646_bib0020","first-page":"5710","article-title":"Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters","volume":"13","author":"DesJardins","year":"1993","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.tranon.2025.102646_bib0021","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.89.16.7452","article-title":"MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination","volume":"89","author":"Bossone","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"32","key":"10.1016\/j.tranon.2025.102646_bib0022","doi-asserted-by":"crossref","first-page":"20603","DOI":"10.1074\/jbc.273.32.20603","article-title":"Genomic organization and expression of a human gene for Myc-associated zinc finger protein (MAZ)","volume":"273","author":"Song","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2025.102646_bib0023","article-title":"MAZ mediates the cross-talk between CT-1 and NOTCH1 signaling during gliogenesis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9765-7","article-title":"MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells","volume":"111","author":"Wang","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s13046-019-1374-x","article-title":"MAZ promotes 6cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway","volume":"38","author":"Yang","year":"2019","journal-title":"J. Experim. Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2025.102646_bib0026","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.2147\/OTT.S274215","article-title":"MicroRNA-29b-3p inhibits the migration and invasion of gastric cancer cells by regulating the autophagy-associated protein MAZ","volume":"14","author":"Zhao","year":"2021","journal-title":"Oncol. Targets Ther."},{"issue":"52","key":"10.1016\/j.tranon.2025.102646_bib0027","doi-asserted-by":"crossref","first-page":"86420","DOI":"10.18632\/oncotarget.13416","article-title":"MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.tranon.2025.102646_bib0028","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2010.12.012","article-title":"The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation","volume":"1813","author":"Plotnikov","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0029","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","article-title":"TNF and MAP kinase signalling pathways","volume":"26","author":"Sabio","year":"2014","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"MMBR"},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0031","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tranon.2025.102646_bib0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pharmthera.2017.02.006","article-title":"Targeting TRK family proteins in cancer","volume":"173","author":"Khotskaya","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.tranon.2025.102646_bib0033","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.trecan.2018.07.002","article-title":"Protein-Protein interactions: emerging oncotargets in the RAS-ERK pathway","volume":"4","author":"Garc\u00eda-G\u00f3mez","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0034","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/REP-14-0220","article-title":"FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure, aging, and cancer","volume":"149","author":"Bhartiya","year":"2015","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1998.9256","article-title":"Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma","volume":"250","author":"Bang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.tranon.2025.102646_bib0036","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/cancers13123026","article-title":"MAPK\/ERK signaling pathway in hepatocellular carcinoma","volume":"13","author":"Moon","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.tranon.2025.102646_bib0037","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neo.2018.07.002","article-title":"Downregulation of Rap1Gap: a switch from DCIS to invasive breast carcinoma via ERK\/MAPK activation","volume":"20","author":"Shah","year":"2018","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0038","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s13046-019-1359-9","article-title":"Estrogen receptor \u03b2 inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy","volume":"38","author":"Song","year":"2019","journal-title":"J. Experim. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.tranon.2025.102646_bib0039","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.tranon.2025.102646_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbrc.2019.12.064","article-title":"UBE2C promotes the progression of head and neck squamous cell carcinoma","volume":"523","author":"Jin","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0041","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1186\/s12885-021-08634-6","article-title":"Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"issue":"Pt 2","key":"10.1016\/j.tranon.2025.102646_bib0042","article-title":"UBE2C regulates the KEAP1\/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy","volume":"276","author":"Jiang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0043","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/biom11010037","article-title":"UBE2C Drives Human cervical cancer progression and is positively modulated by mTOR","volume":"11","author":"Chiang","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0044","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.21037\/jgo-22-516","article-title":"UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation","volume":"13","author":"Cao","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1158\/1541-7786.MCR-22-0825","article-title":"UBE2C-mediated autophagy inhibition via ubiquitination of SIRT1 contributes to endometrial cancer progression","volume":"21","author":"Zhao","year":"2023","journal-title":"MCR"},{"issue":"4","key":"10.1016\/j.tranon.2025.102646_bib0046","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162434","article-title":"The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells","volume":"133","author":"Zhang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tranon.2025.102646_bib0047","article-title":"UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0048","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41594-020-0424-6","article-title":"Ubiquitin chain-elongating enzyme UBE2S activates the RING E3 ligase APC\/C for substrate priming","volume":"27","author":"Martinez-Chacin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0049","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.bjc.6605122","article-title":"Validation of UBE2C protein as a prognostic marker in node-positive breast cancer","volume":"101","author":"Loussouarn","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2025.102646_bib0050","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/annonc\/mdr527","article-title":"Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study","volume":"23","author":"Psyrri","year":"2012","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0051","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1039\/c2ib20215h","article-title":"Evaluation of the shear force of single cancer cells by vertically aligned carbon nanotubes suitable for metastasis diagnosis","volume":"5","author":"Abdolahad","year":"2013","journal-title":"Integr. Biol."},{"key":"10.1016\/j.tranon.2025.102646_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102217","article-title":"Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3","volume":"80","author":"Wang","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.tranon.2025.102646_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217201","article-title":"MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1\/2 activation","volume":"602","author":"Zeng","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.tranon.2025.102646_bib0054","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41419-024-06835-y","article-title":"MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0055","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s42003-024-07209-y","article-title":"Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma","volume":"7","author":"Feng","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0056","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12935-021-02020-9","article-title":"Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway","volume":"21","author":"Ren","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"50","key":"10.1016\/j.tranon.2025.102646_bib0057","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41388-024-03194-y","article-title":"MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.tranon.2025.102646_bib0058","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1074\/jbc.274.5.3076","article-title":"Characterization of the human endothelial nitric-oxide synthase promoter","volume":"274","author":"Karantzoulis-Fegaras","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0059","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-1119(01)00328-6","article-title":"Characterization and promoter analysis of the mouse gene for transcription factor Sp4","volume":"264","author":"Song","year":"2001","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.tranon.2025.102646_bib0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/hep.21675","article-title":"X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter","volume":"46","author":"Su","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.tranon.2025.102646_bib0061","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/1541-7786.MCR-10-0598","article-title":"Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity","volume":"9","author":"Ray","year":"2011","journal-title":"MCR"},{"issue":"4","key":"10.1016\/j.tranon.2025.102646_bib0062","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/genes9040188","article-title":"UBE2C Is a transcriptional target of the cell cycle regulator FOXM1","volume":"9","author":"Nicolau-Neto","year":"2018","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0063","doi-asserted-by":"crossref","DOI":"10.1515\/med-2023-0757","article-title":"Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance","volume":"18","author":"Long","year":"2023","journal-title":"Open Med."},{"issue":"13","key":"10.1016\/j.tranon.2025.102646_bib0064","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.3390\/ijms23137353","article-title":"Immunomodulatory properties of PI3K\/AKT\/mTOR and MAPK\/MEK\/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative breast cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2025.102646_bib0065","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102646_bib0066","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12032-015-0609-8","article-title":"Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway","volume":"32","author":"Zhang","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tranon.2025.102646_bib0067","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fphar.2018.00847","article-title":"UBE2C Is a potential biomarker of intestinal-type gastric cancer with chromosomal instability","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102646_bib0068","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12935-021-02020-9","article-title":"Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway","volume":"21","author":"Ren","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.tranon.2025.102646_bib0069","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cam4.362","article-title":"Induction of Ras by SAF-1\/MAZ through a feed-forward loop promotes angiogenesis in breast cancer","volume":"4","author":"Ray","year":"2015","journal-title":"Cancer Med."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:55:55Z","timestamp":1781178955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S1936523325003778"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102646","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102646"}}